175609-19-5 Usage
General Description
2,1,3-Benzoxadiazol-4-ylmethanol is a chemical compound with the molecular formula C8H7NO2. It is commonly used as a fluorescent labeling reagent in various biochemical and biotechnological applications. 2,1,3-BENZOXADIAZOL-4-YLMETHANOL is known for its high quantum yield and exceptional photostability, making it a popular choice for fluorescent labeling in diverse biological studies. Additionally, it has been utilized in the development of fluorescent dyes and probes for detecting specific biomolecules and for imaging applications. The unique properties of 2,1,3-Benzoxadiazol-4-ylmethanol make it a valuable tool in the field of molecular and cellular biology.
Check Digit Verification of cas no
The CAS Registry Mumber 175609-19-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,6,0 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 175609-19:
(8*1)+(7*7)+(6*5)+(5*6)+(4*0)+(3*9)+(2*1)+(1*9)=155
155 % 10 = 5
So 175609-19-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H6N2O2/c10-4-5-2-1-3-6-7(5)9-11-8-6/h1-3,10H,4H2
175609-19-5Relevant articles and documents
Benzofurazanyl- and benzofuroxanyl-1,4-dihydlropyridines : Synthesis, structure and calcium entry blocker activity
Gasco,Ermondi,Fruttero,Gasco
, p. 3 - 10 (1996)
The synthesis, structural characterization and calcium blocking activity of a series of benzofurazanyl-1,4-dihydropyridines (18 and 19) and benzofuroxanyl analogues (20 and 21) are reported. 1H-NMR showed that all the benzofuroxan derivatives exist in solution as tautomeric mixtures. The predominant tautomeric form in solution of the derivative 20 (dimethyl 1,4-dihydro-2,6-dimethyl-4-(4-benzofuroxanyl)-3,5-pyridinedicarboxylate) is also the one preferred in the solid state as shown by X-ray analysis. The conformation in the solid state of the benzofurazanyl analogue is also reported. Calcium entry blocker activity of the dihydropyridine derivatives 18-21 has been evaluated in isolated rabbit basilar artery as relaxation of calcium-induced contractions in high K+-depolarizing solution. All the compounds displayed high potency. The activity of benzofurazan derivatives was not changed by the N-oxidation. The two most active compounds 18 and 20 were as potent as Nifedipine.
